:: Jun-Jul 2008

Welcome to our Monthly Online Newsletter!

NGC - Anticoagulation therapy supplement. (2005)

NGC - Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (2004)

NGC - Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (2004)

NGC - Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology. (2004)

NGC - Use of nonsteroidal antiinflammatory drugs: an update for clinicians. A scientific statement from the American Heart Association. (2007)

Featured site

NIH - Salicylates (Systemic)

Aspirin

NIH - Aspirin and Codeine

NIH - Medical Encyclopedia Aspirin overdose

Cardiovascular: General

Cardiovascular: Stroke

Pain Management

Cardiovascular: General

Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged 70 (BMJ 2005) "Objective To investigate the routine use of low dose aspirin in people aged 70 without overt cardiovascular disease. Ä Conclusion Epidemiological modelling suggests that any benefits of low dose aspirin on risk of cardiovascular disease in people aged 70 are offset by adverse events. These findings are tempered by wide confidence intervals, indicating that the overall outcome could be beneficial or adverse."

Cardiovascular: Stroke

The significance of prestroke aspirin dosage in fatal outcome of acute stroke. (Clin Neuropharmacol. 2005) "BACKGROUND: Aspirin is an effective and generally accepted treatment drug during the acute stage of ischemic brain infarction. Ä CONCLUSION: Prestroke medium-dose aspirin treatment was associated with reduced 30-day poststroke mortality, whereas low-dose prestroke aspirin therapy was associated with increased 30-day poststroke mortality."